Sheena Josselyn recognized by American Association for the Advancement of Science

Sheena Josselyn, a senior scientist at The Hospital for Sick Children (SickKids) and a professor in the department of psychology in the Faculty of Arts & Science and the department of physiology in the Temerty Faculty of Medicine, has been elected a 2023 American Association for the Advancement of Science (AAAS) Fellow.

The AAAS is one of the world’s largest scientific societies and publisher of the Science family of journals. Its fellowships, launched in 1874, represent a distinguished lifetime honour within the scientific community.

Josselyn, who holds a Canada Research Chair in Brain Mechanisms Underlying Memory, was recognized for her contributions to the field of neuroscience, particularly for establishing the existence of engrams – physical or chemical changes in the brain that correspond to memories.

Understanding how engrams are formed and connected in the brain may lead to effective therapies that target conditions disrupting memories, such as Alzheimer’s disease.

The 2023 AAAS Fellows were announced in April 2024.

Read the AAAS announcement

UTC

Top Story (Hub page)

Off

Patricia Brubaker receives Diabetes Canada Lifetime Achievement Award

lanthierj — Fri, 06 Nov 2020 17:03:04 +0000

Patricia Brubaker receives Diabetes Canada Lifetime Achievement Award

Research & Innovation

lanthierj Fri, 11/06/2020 - 12:03

Faculty

St. George

Temerty Faculty of Medicine

Donnelly Centre for Cellular & Biomolecular Research

Department of Physiology

Women in STEM

landscape

(photo by Johnny Guatto)

Professor Patricia Brubaker of the �ؿ�ζSM’s Temerty Faculty of Medicine is the first woman to receive the Diabetes Canada Lifetime Achievement Award.

The award recognizes a Canadian medical doctor or scientist for their leadership in diabetes research and longstanding contributions to the diabetes community in Canada.

“When I think about lifetime achievement, I think about the joy of discovery,” Brubaker said. “That eureka moment keeps me going. I would say my most significant contributions have been my work on the implications of glucagon-like peptide 1 in diabetes, as well as the discovery and application of glucagon-like peptide 2 as a new treatment for short bowel syndrome.

“Aside from the discovery aspect, my lifetime achievement has been the joy of interacting with my amazing trainees who challenge me and keep me engaged. I have a wall of photographs in my office...I think I have one up of every person I’ve trained. Those relationships I have built over the years are a real source of pride.”

Brubaker was nominated for the award by renowned U of T endocrinologist Professor Daniel Drucker. He said Brubaker, a Canada Research Chair and fellow of the Royal Society of Canada, is “one of the most honest and critical scientists I've been privileged to work with” as well as one of the most unselfish, volunteering her time to fill numerous leadership positions.

“As Professor Brubaker's work has shown us over the last several decades, she has become one of the international leaders in the biology of the glucagon-like peptides,” Drucker said in a congratulatory video. “This work has had tremendous translational impact and Pat has been at the forefront of this exciting wave of research.

“Although she is receiving the lifetime achievement award, she continues to carry out research at the highest level, even today.”

Physiology

Top Story (Hub page)

Off